Cardiology

The Important Role of Lipoprotein(a) in Cardiovascular Disease: Present and Future Therapeutic Options
http://academiccme.com/wp-content/uploads/2018/02/Screen-Shot-2018-03-05-at-12.10.56-PM-wpcf_80x80.png
The content for this activity is derived from a live symposium titled, “The Important Role of Lipoprotein(a) in Cardiovascular Disease: Present and Future Therapeutic Options” presented at the American Heart Association Scientific Sessions 2017 in Anaheim, California…
Webcast
Applying PCSK9 Inhibitors to Optimize Outcomes in Patients With Dyslipidemia
http://academiccme.com/wp-content/uploads/2017/12/AHA_E-125-x-125-wpcf_80x80.jpg
The content for this activity is derived from a live symposium titled, “Applying PCSK9 Inhibitors to Optimize Outcomes in Patients With Dyslipidemia” presented at the American Heart Association Scientific Sessions 2017 in Anaheim, California…
Webcast
Advances in the Prevention and Long-Term Management of Venous Thromboembolism
http://academiccme.com/wp-content/uploads/2017/11/iStock-641133986-wpcf_80x80.jpg
This CME webcast will focus on the advances in the prevention and long-term management of venous thromboembolism (VTE)…
Webcast
The Role of PCSK9 Inhibitors in Lowering LDL-C and Reducing Cardiovascular Risk in Patients With Dyslipidemia
http://academiccme.com/wp-content/uploads/2017/10/910748-125-x-125-wpcf_80x80.jpg
This CME program will feature content presented at the European Society of Cardiology (ESC) Congress 2017 in Barcelona, Spain…
Meeting Reporter
Optimizing Patient Outcomes in the Era of PCSK9 Inhibitor Therapeutics
http://academiccme.com/wp-content/uploads/2017/06/910713-125-x-125-wpcf_80x80.jpg
This activity will focus on the most current clinical trial data for optimizing patient outcomes in the era of PCSK9 inhibitor therapeutics presented as an Industry-Supported Symposium at the National Lipid Association 2017 Scientific Sessions…
Webcast